Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | MDM2 | Q00987 | 6/20 | 0.52 |
| ▸ | MDM4 | O15151 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | TLR2 | O60603 | 2/20 | 0.51 |
| ▸ | CASP3 | P42574 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18237098 | 1.00 | KMT2A (0.53) | KMT2AMDM2MDM4TP53TLR2 | |
| SCHEMBL29514568 | 1.00 | KMT2A (0.53) | KMT2AMDM2MDM4TP53TLR2 | |
| SCHEMBL26093325 | 1.00 | KMT2A (0.53) | KMT2AMDM2MDM4TP53TLR2 | |
| SCHEMBL15521165 | 1.00 | KMT2A (0.53) | KMT2AMDM2MDM4TP53TLR2 | |
| SCHEMBL120403 | 1.00 | KMT2A (0.53) | KMT2AMDM2MDM4TP53TLR2 | |
| SCHEMBL29401239 | 1.00 | KMT2A (0.53) | KMT2AMDM2MDM4TP53TLR2 | |
| Hydrochloric Acid SCHEMBL9661481 | 0.99 | KMT2A (0.52) | KMT2AMDM2MDM4TP53TLR2 | |
| Hydrochloric Acid SCHEMBL29365362 | 0.99 | KMT2A (0.52) | KMT2AMDM2MDM4TP53TLR2 | |
| Hydrochloric Acid SCHEMBL29400592 | 0.99 | KMT2A (0.52) | KMT2AMDM2MDM4TP53TLR2 | |
| SCHEMBL29432853 | 0.97 | KMT2A (0.54) | KMT2AMDM2MDM4TP53TLR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114948860-A | Supermolecule hydrogel nano material, gelator, preparation method and application thereof | 东南大学 | 2022-08-30 | — | — | CN | claimed |
| US-20260022143-A1 | Cyclic Peptide Inhibitors of IL-23 | JANSSEN PHARMACEUTICA NV (BE) | 2026-01-22 | — | — | US | disclosed |
| CN-114948860-A | Supermolecule hydrogel nano material, gelator, preparation method and application thereof | 东南大学 | 2022-08-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022143-A1 | Cyclic Peptide Inhibitors of IL-23 | IL23R, IL17A, IL36G | KMT2A 958/4885MDM2 4433/4885MDM4 4631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.